Quinolines and derivatives
- (1)
- (1)
- (1)
- (226)
- (6)
- (1)
- (1)
- (40)
- (2)
- (12)
- (48)
- (1)
- (37)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (8)
- (136)
- (1)
- (10)
- (16)
- (1)
- (37)
- (1)
- (1)
- (1)
- (1)
- (1)
- (190)
- (1)
- (1)
- (17)
- (1)
- (19)
- (17)
- (7)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (8)
- (21)
- (26)
- (2)
- (30)
- (4)
- (6)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (5)
- (2)
- (6)
- (5)
- (2)
- (1)
- (11)
- (1)
- (2)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (25)
- (16)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (4)
- (4)
- (8)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (2)
- (1)
- (1)
- (2)
- (1)
- (6)
- (1)
- (20)
- (1)
- (5)
- (1)
- (3)
- (5)
- (1)
- (2)
- (2)
- (2)
- (2)
- (8)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (4)
- (2)
- (2)
- (1)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (2)
- (5)
- (2)
- (4)
- (2)
- (3)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (4)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (3)
- (1)
- (7)
- (2)
- (1)
- (4)
- (1)
- (1)
- (1)
- (2)
- (2)
- (4)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (2)
- (3)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (13)
- (1)
- (1)
- (2)
- (2)
- (4)
- (3)
- (4)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (19)
- (2)
- (1)
- (2)
- (4)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (4)
- (5)
- (1)
- (2)
- (1)
- (1)
- (2)
- (4)
- (3)
- (2)
- (1)
- (9)
- (5)
- (2)
- (3)
- (3)
- (2)
- (5)
- (6)
- (3)
- (13)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (1)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (4)
- (5)
- (4)
- (3)
- (3)
- (7)
- (1)
- (1)
- (2)
- (3)
- (7)
- (5)
- (2)
- (1)
- (10)
- (1)
- (1)
- (1)
- (2)
- (2)
- (4)
- (1)
- (2)
- (2)
- (4)
- (2)
- (2)
- (6)
- (2)
- (7)
- (4)
- (3)
- (2)
- (2)
- (5)
- (2)
- (1)
- (14)
- (1)
- (1)
- (23)
- (42)
- (24)
- (18)
- (83)
- (3)
- (17)
- (3)
- (5)
- (8)
- (1)
- (6)
- (1)
- (5)
- (1)
- (1)
- (6)
- (5)
- (2)
- (5)
- (2)
- (6)
- (2)
- (2)
- (4)
- (1)
- (26)
- (19)
- (71)
- (1)
- (110)
- (3)
- (1)
- (2)
- (63)
- (5)
- (1)
- (1)
- (2)
- (299)
- (2)
- (2)
- (25)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (3)
- (9)
- (3)
- (2)
- (62)
- (2)
- (5)
- (29)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (3)
- (2)
- (1)
- (1)
- (2)
- (1)
- (5)
- (4)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (5)
- (3)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (12)
- (4)
- (1)
- (5)
- (3)
- (5)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (3)
- (5)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
Filtered Search Results
Medchemexpress LLC Iniparib (BSI-201) | 160003-66-7 | 99.7% | 200 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Iniparib (BSI-201) is an irreversible poly(ADP-ribose) polymerase 1 (PARP1) inhibitor supplied for research use. It is used in preclinical and translational studies, notably in triple-negative breast cancer research, and is provided as a purified solid suitable for laboratory experiments.
- Irreversible inhibitor of PARP1.
- Commonly used in triple-negative breast cancer research.
- Supplied as a high-purity research-grade compound.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC N,S-diacetyl-L-cysteine | 18725-37-6 | 99.4% | 200MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
N,S-diacetyl-L-cysteine | 18725-37-6 | 99.4% | 200MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 4965-36-0 | 7-Bromoquinoline | Ambeed | MFCD03695823 | 208.058 | C9H6BrN | 98.000 | Brc1ccc2cccnc2c1 | 5g | 490534630
7-Bromoquinoline | Ambeed | 4965-36-0 | MFCD03695823 | 208.058 | C9H6BrN | 98.000 | Brc1ccc2cccnc2c1 | 5g | 490534630
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Methyl phenyl sulfone | 3112-85-4 | MFCD00014741 | 50g
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Methyl phenyl sulfone is a drug impurity
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 3-sulfo-taurocholic acid disodium salt | 71781-33-4 | 99.0% | 639.73 | C26H43NNa2O10S2 | 1mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
3-Sulfo-taurocholic Acid Disodium Salt (3-Sulfocholyl Taurine TCA3S) is a metabolite of the conjugated bile acid taurocholic acid Plasma levels of 3-Sulfo-taurocholic Acid Disodium Salt are elevated in wild-type and Sortilin 1 (Sort1) knockout mice at 6 hours following bile duct ligation (BDL) and are further elevated in Sort1 knockout mice at 24 hours post-BDL
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 3,6,9,12,15,18,21,24,27,30-decaoxadotriacontane-1,32-diamine | 928292-69-7 | MFCD28122962 | ≥97.0% | 500.62 g/mol | C22H48N2O10 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Amino-PEG10-amine is a polyethylene glycol (PEG10) diamine linker bearing primary amino groups at both termini. It is used as a hydrophilic, flexible spacer for PROTAC synthesis, bioconjugation, and crosslinking, providing improved solubility and coupling handle accessibility.
- Provides two terminal primary amines for covalent coupling.
- PEG10 spacer increases solubility in aqueous media.
- High purity suitable for research and synthesis (≥97% by NMR).
- Flexible spacer for linker design in PROTAC and bioconjugation applications.
- Stable when stored protected from light at recommended temperatures.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
![eMolecules 3945-69-5 | 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride | Combi-Blocks | MFCD03613550 | 276.720 | C10H17ClN4O3 | 95.000 | [Cl-].COc1nc(OC)nc(n1)[N+]1(C)CCOCC1 | 100g | 267182017](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000225212.jpg-250.jpg)
eMolecules 3945-69-5 | 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride | Combi-Blocks | MFCD03613550 | 276.720 | C10H17ClN4O3 | 95.000 | [Cl-].COc1nc(OC)nc(n1)[N+]1(C)CCOCC1 | 100g | 267182017
4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride | Combi-Blocks | 3945-69-5 | MFCD03613550 | 276.720 | C10H17ClN4O3 | 95.000 | [Cl-].COc1nc(OC)nc(n1)[N+]1(C)CCOCC1 | 100g | 267182017
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
![eMolecules 898747-24-5 | 5-Bromo-1H-indazole-7-carboxylic acid methyl ester | J & W PharmLab LLC | MFCD08458991 | 255.071 | C9H7BrN2O2 | 96.000 | COC(=O)c1cc(Br)cc2cn[nH]c12 | 5g | 289352063](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000225216.jpg-250.jpg)
eMolecules 898747-24-5 | 5-Bromo-1H-indazole-7-carboxylic acid methyl ester | J & W PharmLab LLC | MFCD08458991 | 255.071 | C9H7BrN2O2 | 96.000 | COC(=O)c1cc(Br)cc2cn[nH]c12 | 5g | 289352063
5-Bromo-1H-indazole-7-carboxylic acid methyl ester | J & W PharmLab LLC | 898747-24-5 | MFCD08458991 | 255.071 | C9H7BrN2O2 | 96.000 | COC(=O)c1cc(Br)cc2cn[nH]c12 | 5g | 289352063
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 90905-32-1 | 2-Methoxypyrimidine-5-carbaldehyde | Synthonix - Stock | MFCD03446732 | 138.126 | C6H6N2O2 | 97.000 | COc1ncc(C=O)cn1 | 5g | 483373818
2-Methoxypyrimidine-5-carbaldehyde | Synthonix - Stock | 90905-32-1 | MFCD03446732 | 138.126 | C6H6N2O2 | 97.000 | COc1ncc(C=O)cn1 | 5g | 483373818
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
![eMolecules 957486-82-7 | AZIDO-PEG6-AMINE | AstaTech | MFCD03453240 | 350.416 | C14H30N4O6 | 95.000 | NCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-] | 0.25g | 490832280](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000225607.jpg-250.jpg)
eMolecules 957486-82-7 | AZIDO-PEG6-AMINE | AstaTech | MFCD03453240 | 350.416 | C14H30N4O6 | 95.000 | NCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-] | 0.25g | 490832280
AZIDO-PEG6-AMINE | AstaTech | 957486-82-7 | MFCD03453240 | 350.416 | C14H30N4O6 | 95.000 | NCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-] | 0.25g | 490832280
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 3,6,9,12,15,18,21,24,27,30-decaoxadotriacontane-1,32-diamine | 928292-69-7 | MFCD28122962 | ≥97.0% | 500.62 g/mol | C22H48N2O10 | 250 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Amino-PEG10-amine is a polyethylene glycol (PEG10) diamine linker used in PROTAC synthesis to connect ligands and improve solubility and flexibility. It is supplied as a high-purity chemical building block for medicinal chemistry and linker design.
- PEG10 diamine linker for PROTAC synthesis.
- Molecular weight 500.62 g/mol.
- Chemical formula C22H48N2O10.
- Purity ≥97.0% (NMR) as per COA.
- Appearance: colorless to light yellow, solid-liquid mixture.
- Storage: 4°C, protect from light; in solvent: -80°C (6 months) or -20°C (1 month).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 90905-32-1 | 2-methoxypyrimidine-5-carbaldehyde | ChemBridge - BB | MFCD03446732 | 138.126 | C6H6N2O2 | 95.000 | COc1ncc(C=O)cn1 | 5g | 331138871
2-methoxypyrimidine-5-carbaldehyde | ChemBridge - BB | 90905-32-1 | MFCD03446732 | 138.126 | C6H6N2O2 | 95.000 | COc1ncc(C=O)cn1 | 5g | 331138871
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Ruboxistaurin mesylate | 192050-59-2 | MFCD09970504 | 99.9% | 564.65 | C29H32N4O6S | 25 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Ruboxistaurin mesylate is the methanesulfonate salt of ruboxistaurin, a potent, orally active, ATP-competitive inhibitor of protein kinase C beta (PKCβ). It exhibits low-nanomolar potency against PKCβ isoforms and is supplied as a high-purity solid for in vitro and preclinical research into PKCβ-related signaling, diabetic complications, and cardiovascular or ocular disease models.
- Selective PKCβ inhibition (IC50 ≈ 4.7-5.9 nM).
- High purity suitable for research use.
- Mesylate salt form with DMSO solubility for assay preparation.
- Supplied as a characterized solid with batch documentation.
- Appropriate for in vitro and preclinical pathway and disease-model studies.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Nutlin-3a 200mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Nutlin-3a (Rebemadlin) an active enantiomer of Nutlin-3 is a potent murine double minute (MDM2) inhibitor (IC50 90 nM) Nutlin-3a inhibits MDM2-p53 interactions and stabilizes the p53 protein and induces cell autophagy and apoptosis Nutlin-3a has the potential for the study of TP53 wild-type ovarian carcinomas1]2]
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
![Medchemexpress LLC 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate | 406205-74-1 | MFCD09027365 | 98.6% | 453.36 g/mol | C18H13F6NO4S | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000214106.png-250.jpg)
Medchemexpress LLC 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate | 406205-74-1 | MFCD09027365 | 98.6% | 453.36 g/mol | C18H13F6NO4S | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Bay 59-3074 is a selective cannabinoid CB1/CB2 receptor partial agonist with demonstrated analgesic activity. It binds human CB1 and CB2 receptors (Ki 48.3 nM and 45.5 nM) and shows antihyperalgesic and antiallodynic effects in rodent pain models.
- Selective CB1/CB2 receptor partial agonist.
- High affinity for human CB1 (Ki ~48.3 nM) and CB2 (Ki ~45.5 nM).
- Demonstrated antihyperalgesic and antiallodynic effects in rodent models.
- High purity (98.6%) and solid, white to off-white appearance.
- Highly soluble in DMSO (≥ 100 mg/mL).
- Stable when stored as powder at -20°C (up to 3 years) or 4°C (up to 2 years).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More